116 related articles for article (PubMed ID: 5660908)
1. [The dynamics of resistance to plague in white mice innoculated once with plague microbe fraction 1].
Basova NN; Filimonova IuA
Biull Eksp Biol Med; 1968 Feb; 65(2):83-6. PubMed ID: 5660908
[No Abstract] [Full Text] [Related]
2. The F1 and V subunit vaccine protects against plague in the absence of IL-4 driven immune responses.
Elvin SJ; Williamson ED
Microb Pathog; 2000 Oct; 29(4):223-30. PubMed ID: 10993741
[No Abstract] [Full Text] [Related]
3. [Early protection of animals, immunized by a recombinant plague vaccine, from experimental plague].
Gremiakova TA; Amel'chenko VA; Anisimov GA
Biull Eksp Biol Med; 1995 Jan; 119(1):54-7. PubMed ID: 7718805
[No Abstract] [Full Text] [Related]
4. Neutralization of Yersinia pestis-mediated macrophage cytotoxicity by anti-LcrV antibodies and its correlation with protective immunity in a mouse model of bubonic plague.
Zauberman A; Cohen S; Levy Y; Halperin G; Lazar S; Velan B; Shafferman A; Flashner Y; Mamroud E
Vaccine; 2008 Mar; 26(13):1616-25. PubMed ID: 18304706
[TBL] [Abstract][Full Text] [Related]
5. Protection against aerosolized Yersinia pestis challenge following homologous and heterologous prime-boost with recombinant plague antigens.
Glynn A; Roy CJ; Powell BS; Adamovicz JJ; Freytag LC; Clements JD
Infect Immun; 2005 Aug; 73(8):5256-61. PubMed ID: 16041052
[TBL] [Abstract][Full Text] [Related]
6. Concomitant administration of Yersinia pestis specific monoclonal antibodies with plague vaccine has a detrimental effect on vaccine mediated immunity.
Eyles JE; Butcher WA; Titball RW; Hill J
Vaccine; 2007 Oct; 25(42):7301-6. PubMed ID: 17869388
[TBL] [Abstract][Full Text] [Related]
7. Expression of Yersinia pestis V antigen in attenuated salmonella typhimurium: development of a novel vaccine for plague.
Leary SE; Eley SM; Williamson ED; Titball RW
Contrib Microbiol Immunol; 1995; 13():216-7. PubMed ID: 8833838
[No Abstract] [Full Text] [Related]
8. [Conversion of pulmonary plague to bubonic plague by oral vaccination with Pasteurella rodentiae].
Muftic M; Kemal R
Z Gesamte Hyg; 1968 Sep; 14(9):724-6. PubMed ID: 5734232
[No Abstract] [Full Text] [Related]
9. [Experimental protective of fraction I of the plague microbe].
Pautov VN; Chicherin IuV; Evstigneev VI; Byvalov AA; Kedrov OA
Zh Mikrobiol Epidemiol Immunobiol; 1979 Oct; (10):37-42. PubMed ID: 116458
[TBL] [Abstract][Full Text] [Related]
10. Expression of an F1/V fusion protein in attenuated Salmonella typhimurium and protection of mice against plague.
Leary SE; Griffin KF; Garmory HS; Williamson ED; Titball RW
Microb Pathog; 1997 Sep; 23(3):167-79. PubMed ID: 9281474
[TBL] [Abstract][Full Text] [Related]
11. [Resistance to plague of mice experimentally infected with "Yersinia enterocolitica" (author's transl)].
Alonso JM; Joseph-François A; Mazigh D; Bercovier H; Mollaret HH
Ann Microbiol (Paris); 1978; 129B(2):203-7. PubMed ID: 718023
[No Abstract] [Full Text] [Related]
12. [Transplacental transmission of antibodies to fraction I of the plague bacillus to progeny of experimental animals].
Gerasiuk LG
Biull Eksp Biol Med; 1966 Oct; 62(10):79-81. PubMed ID: 6005604
[No Abstract] [Full Text] [Related]
13. [Diagnostic value of serological reactions for detecting antibodies against the plague microbe].
Peĭsakhis LA; Larionov GM; Stepanov VM
Lab Delo; 1973; 3():162-5. PubMed ID: 4129113
[No Abstract] [Full Text] [Related]
14. CpG oligodeoxynucleotides augment the murine immune response to the Yersinia pestis F1-V vaccine in bubonic and pneumonic models of plague.
Amemiya K; Meyers JL; Rogers TE; Fast RL; Bassett AD; Worsham PL; Powell BS; Norris SL; Krieg AM; Adamovicz JJ
Vaccine; 2009 Apr; 27(16):2220-9. PubMed ID: 19428836
[TBL] [Abstract][Full Text] [Related]
15. Application of the antibody neutralization reaction in differential diagnosis of the etiologic agent of plague and the study of mutual relations between the amount of fraction I and virulence in strains of the plague microbe (Pasteurella pestis).
Timofeeva LA; Aparin GP
J Hyg Epidemiol Microbiol Immunol; 1968; 12(4):420-5. PubMed ID: 5752128
[No Abstract] [Full Text] [Related]
16. [Protective activity of the recombinant strain Salmonella minnesota R595/GSA, synthesizing the plague capsule antigen in experimental plague in mice].
Gremiakova TA; Stepanshina VN; Korobova OV; Anisimov GA
Mol Gen Mikrobiol Virusol; 1994; (1):23-6. PubMed ID: 8133846
[TBL] [Abstract][Full Text] [Related]
17. Stat 4 but not Stat 6 mediated immune mechanisms are essential in protection against plague.
Elvin SJ; Williamson ED
Microb Pathog; 2004 Oct; 37(4):177-84. PubMed ID: 15458778
[TBL] [Abstract][Full Text] [Related]
18. Large-scale purification of the F1 antigen of Yersinia pestis.
Reddin KM; Easterbrook TJ; Robinson A; Williamson D; Rhind-tutt R
Contrib Microbiol Immunol; 1995; 13():329-30. PubMed ID: 8833865
[No Abstract] [Full Text] [Related]
19. Small protective fragments of the Yersinia pestis V antigen.
Vernazza C; Lingard B; Flick-Smith HC; Baillie LW; Hill J; Atkins HS
Vaccine; 2009 May; 27(21):2775-80. PubMed ID: 19366573
[TBL] [Abstract][Full Text] [Related]
20. Protection against plague afforded by immunisation with DNA vaccines optimised for expression of the Yersinia pestis V antigen.
Garmory HS; Freeman D; Brown KA; Titball RW
Vaccine; 2004 Feb; 22(8):947-57. PubMed ID: 15161071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
